What are you searching for…

Why O<sub>2</sub> levels are critically important in cell-based research - View on demand webinar!

30-04-2021

Why O2 levels are critically important in cell-based research - View on demand webinar!

Discover why controlled O2 levels are critically important in cell-based research in our latest webinar. 

Now available on demand! 

Discovery of New Genetic Biomarkers

16-04-2021

Discovery of New Genetic Biomarkers

Researchers at Wake Forest School of Medicine say that they have identified a set of new genetic bio markers.

These markers could potentially lead to new personalized treatments for lung cancer.

Find out more!

TCR2 Therapeutics Inc.

12-04-2021

TCR2 Therapeutics Inc.

TCR2 Therapeutics Inc., a clinical stage-cell therapy company with a pipeline of novel T cell therapies for patients suffering from cancer is expanding to a facility in Rockville, Maryland.

The expansion will accelerate the development of its lead program, Gavo-Cell in 2021.

Read more.

Dr. Ox Interview Series

07-04-2021

Dr. Ox Interview Series

Discover the next interview in the series as Dr. Ox continues to interview leading scientists.

Featuring Hans Clevers of Hubrecht Institute, learn more about his role in Developmental Biology and Stem Cell Research.

Watch the interview!

T- Cell Immunotherapy

05-04-2021

T- Cell Immunotherapy

Last month, the FDA approved Abecma as the first B-cell maturation antigen (BCMA)- directed chimeric antigen receptor T-cell immunotherapy for patients with relapsed or refractory multiple myeloma.

Find out more.

A Universal Flu Vaccine

03-04-2021

A Universal Flu Vaccine

Encouraging findings, led by scientists at Washington School of Medicine found that a new nanoparticle-based system allows flu vaccines to be assembled in a Lego like manor.

By simplifying the construction of multivalent vaccines, it is also possible to arrange diverse antigens.

Read more!

BSC MythBusters

02-04-2021

BSC MythBusters

Do HEPA filters really filter everything out?

Visit the MythBuster webpage and download Baker’s poster to learn more!

View the MythBuster series!

Multiple Sclerosis & the Immune System

02-04-2021

Multiple Sclerosis & the Immune System

In the case of Multiple Sclerosis and other autoimmune conditions, our immune defences turn on the body rather than protect it.

T cells become activated in the lymph system and then enter the CNS through blood vessels. Once through, they then release chemicals, activating B cells that cause the damage associated with the condition.

Read more for yourself!

Physiological ISO Workstations

01-04-2021

Physiological ISO Workstations

Out of the box thinking, inside the box - from research to GMP.

Learn more about Baker Ruskinn’s Physiological Oxygen ISO Class 3 Workstations!

Download the brochure!

Lab Automation & AeroPROTECT<sup>®</sup>

01-04-2021

Lab Automation & AeroPROTECT®

AeroPROTECT 360° is a truly versatile containment unit for Laboratory Automation.

Complete with Baker’s exclusive technology, you are able to maximize product protection whilst meeting NSF International Standard 49.

Visit the webpage to find out more.

Affibody & Inmagene Pharmaceuticals

30-03-2021

Affibody & Inmagene Pharmaceuticals

Affibody and Inmagene Pharmaceuticals reported that the FDA has cleared the interleukin-17 blocker known as Izokibep.
This means that Phase 2 clinical development into non-infectious intermediate, posterior and pan-uveitis can commence.

Find out more.

Ask us a question? Get in touch

Contact Us